1 / 11

Erectile Dysfunction Drugs Market Declining due to Patent Expiry,Counterfeit Drug Manufacture

The global erectile dysfunction drugs market is set to decline in the coming few years. The report on the global market for erectile dysfunction drugs market delivers an in-depth analysis of the trends responsible for the decline of this market. Additionally, the report provides statistical support to elaborate on the market’s decline.<br>

kksingha
Télécharger la présentation

Erectile Dysfunction Drugs Market Declining due to Patent Expiry,Counterfeit Drug Manufacture

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transparency Market Research Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Published Date 21-Oct-2013 98 Page Report Request Sample Buy Now Press Release Erectile Dysfunction Drugs Market Declining due to Patent Expiry, Counterfeit Drug Manufacture : Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

  2. Erectile Dysfunction Drugs Market REPORT DESCRIPTION Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 The global erectile dysfunction drugs market is set to decline in the coming few years. The report on the global market for erectile dysfunction drugs market delivers an in-depth analysis of the trends responsible for the decline of this market. Additionally, the report provides statistical support to elaborate on the market’s decline. Browse the full report at http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html The global erectile dysfunction drugs market report provides a 360-degree view of the treatments available in the market for erectile dysfunction (ED). These are localized therapy, vacuum constriction devices, PDE 5 inhibitors, testosterone replacement therapy, and alternative medicines. According to brand, the global erectile dysfunction drugs market is divided into Viagra, Cialis, Stendra/Spedra, Levitra/Staxyn, MUSE, Zydena, Mvix, and Helleva. Related & Recently Published Report by Transparency Market Research Self-Administration Drugs Market: http://www.transparencymarketresearch.com/self-administration-drugs-market.html The global erectile dysfunction drugs market research report also evaluates pipeline drugs such as Vitaros, Uprima, and others. Geography-wise, the global erectile dysfunction drugs market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Furthermore, the report also provides strategic recommendations such as cost containment measures, novel drug formulations owing to patent expirations of well-known ED drugs, and M&A tactics to strengthen market presence. Latest Press Release Of This Report: http://www.transparencymarketresearch.com/pressrelease/erectile- dysfunction-drugs.htm Overview of the global erectile dysfunction drugs market Factors such as the growing elderly population, increasing awareness and patient education, elevated inclination towards a sedentary lifestyle, and growing incidence of several genitourinary diseases are expected to drive the growth of the global erectile dysfunction drugs market. Nevertheless, factors such as growing threat from counterfeit drugs, prevalence of STDs in ED drug users, and diminishing insurance coverage for ED treatment will greatly hamper the growth of the market. Browse Article: http://www.transparencymarketresearch.com/article/erectile-dysfunction-drugs.htm 2 Transparency Market Research

  3. Erectile Dysfunction Drugs Market The global erectile dysfunction drugs market will decelerate at a CAGR of 4.5% during the forecast period of 2013 to 2019. In 2012, the global erectile dysfunction drugs market stood at US$4.3 billion and is expected to reach a market value of US$3.4 billion by end of 2019. The North American erectile dysfunction drugs market held substantial market revenue of US$2,098.4 million in 2012. The top three erectile dysfunction drugs in the market are Cialis (tadalafil), Staxyn/Levitra (vardenafil), and Viagra (sildenafil citrate). In 2013, Viagra held the largest market share of 45% in the global erectile dysfunction drugs market. The patent expiration of Viagra, especially outside the U.S., in 2013, along with the loss of patent and marketing exclusivity of the drug Levitra from Bayer AG and Cialis from Eli Lilly in Europe and other countries will result in the market’s steady decline. Nevertheless, the extended patent exclusivity of Viagra till 2020 is anticipated to allow this brand to hold a major market revenue share in the U.S. The market for Cialis is also predicted to demonstrate a decline in revenue during the forecasting horizon. In 2012, Cialis was the second largest drug segment in the global ED drugs market, with revenue of US$1,926.8 million. However, the market for this drug will decline at a 12.6% CAGR during the forecast period. Companies mentioned in the research report Players in the market will tap on the opportunity of novel molecule combinations and innovative drug delivery techniques. The most established companies in the global erectile dysfunction drugs market are Bayer AG, Apricus Biosciences, Dong-A Pharmaceutical, Meda Pharmaceuticals, Eli Lilly And Company, Pfizer, Vivus, and S.K. Chemicals. Major geographies analyzed under this research report are: • Europe • North America • Asia-Pacific • Rest of the World This report gives you access to decisive data such as: • Market growth drivers • Factors limiting market growth • Current market trends • Market structure • Market projections for the coming years 3 Transparency Market Research

  4. Erectile Dysfunction Drugs Market Key highlights of this report • Overview of key market forces propelling and restraining market growth • Up-to-date analyses of market trends and technological improvements • Pin-point analyses of market competition dynamics to offer you a competitive edge • An analysis of strategies of major competitors • An array of graphics and SWOT analysis of major industry segments • Detailed analyses of industry trends • A well-defined technological growth map with an impact-analysis • Offers a clear understanding of the competitive landscape and key product segments Get Sample Report Copy with TOC and Market Research : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1550 TABLE OF CONTENT Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations Chapter 2 Executive Summary Chapter 3 Market Overview 3.1 Introduction to Erectile Dysfunction 3.2 Current Market Trends and Future Outlook 3.2.1 Impact of Generics 3.2.2 Key Patent Expirations 4 Transparency Market Research

  5. Erectile Dysfunction Drugs Market 3.2.3 Ongoing Clinical Trials in the U.S. for ED Treatment (Phase III) 3.3 Types of Treatments for ED 3.3.1 Phosphodiesterase Type 5 Inhibitors (PDE 5 Inhibitors) 3.3.2 Localized Therapy 3.3.3 Testosterone Replacement Therapy 3.3.4 Vacuum Constriction Devices 3.3.5 Surgery (Penile Implants and Vascular Surgery) 3.3.6 Alternative Medicines (Yohimbine and Other Herb and Dietary Supplements) 3.4 Market Drivers 3.4.1 Increase in Elderly Population 3.4.2 Increasing Global Incidence of Various Diseases and Growing Preference Towards Sedentary Lifestyle 3.4.3 Increase in Awareness and Patient Education 3.5 Market Restraints 3.5.1 Prevalence of Sexually Transmitted Diseases with ED Drug Users 3.5.2 Narrowing of Insurance Coverage for Erectile Dysfunction Treatment 3.5.3 Growing Threat from Counterfeit Drugs 3.6 Market Opportunities 3.6.1 Novel Molecule Combinations and Drug Delivery Techniques are Expected to Become a Rising Opportunity 3.6.2 Generics - A Growing Global Opportunity 3.7 Porter’s Five Forces Analysis: Global Erectile Dysfunction Drugs Market 3.7.1 Bargaining Power of Suppliers 3.7.2 Bargaining Power of Buyers 3.7.3 Threat of Substitutes 3.7.4 Threat of New Entrants 3.7.5 Competitive Rivalry 3.8 Market Attractiveness Analysis: Global Erectile Dysfunction Drugs Market, By Geography (2015) Chapter 4 Global Erectile Dysfunction Drugs Market Revenue, By Brand, 2011-2019 (USD Million) 5 Transparency Market Research

  6. Erectile Dysfunction Drugs Market 4.1 Market Overview 4.1.1 Mechanism of Action 4.1.2 Characteristics of Major Phosphodiesterase Type 5 Inhibitors 4.2 Viagra (Sildenafil Citrate) 4.2.1 Introduction 4.2.2 Global Viagra Market for Erectile Dysfunction Treatment, 2010 – 2019 (USD Million) 4.2.3 Patent Expiration and Regulatory Scenario 4.2.3.1 The U.S. Market 4.2.3.2 International Market 4.2.4 Past & Current Market Scenario 4.2.5 Global Viagra Market for Erectile Dysfunction Treatment, 2010 – 2014 (USD Million) 4.2.6 Future Market Scenario 4.2.7 Global Viagra Market for Erectile Dysfunction Treatment, 2015 – 2019 (USD Million) 4.3 Cialis (Tadalafil) 4.3.1 Introduction 4.3.2 Global Cialis Market for Erectile Dysfunction Treatment, 2010 – 2019 (USD Million) 4.3.3 Patent and Regulatory Scenario 4.3.4 Current Market Scenario and Patent Expiry Effect 4.3.5 Global Cialis Market for Erectile Dysfunction Treatment, 2010 – 2014 (USD Million) 4.3.6 Future Market Scenario 4.3.7 Global Cialis Market for Erectile Dysfunction Treatment, 2015 – 2019 (USD Million) 4.4 Levitra/Staxyn (Vardenafil) 4.4.1 Introduction 4.4.2 Global Levitra/Staxyn Market for Erectile Dysfunction Treatment, 2010 – 2019 (USD Million) 4.4.3 Patent and Regulatory Scenario 4.4.4 Current and Future Market Scenario 4.4.5 Global Levitra/Staxyn Market For Erectile Dysfunction Treatment, 2010 – 2014 (USD Million) 4.4.6 Global Levitra/Staxyn Market for Erectile Dysfunction Treatment, 2015 – 2019 (USD Million) 6 Transparency Market Research

  7. Erectile Dysfunction Drugs Market 4.5 Stendra/Spedra (Avanafil) 4.5.1 Introduction 4.5.2 Future Market Scenario 4.5.3 Global Stendra/Spedra Market for Erectile Dysfunction Treatment, 2015 – 2019 (USD Million) 4.6 Zydena (Udenafil) 4.6.1 Introduction 4.6.2 Global Zydena Market for Erectile Dysfunction Treatment, 2010 – 2019 (USD Million) 4.6.3 Current Market Scenario 4.6.4 Global Zydena Market for Erectile Dysfunction Treatment, 2010 – 2014 (USD Million) 4.6.5 Future Market Scenario 4.6.6 Global Zydena Market for Erectile Dysfunction Treatment, 2015 – 2019 (USD Million) 4.7 MUSE (Medicated Urethral System for Erection) 4.7.1 Patent and Regulatory Scenario 4.8 Mvix (Mirodenafil) 4.9 Helleva (Lodenafil Carbonate) Chapter 5 Global Erectile Dysfunction Drugs Market, Pipeline Analysis 5.1 Overview 5.2 Vitaros (Alprostadil) 5.2.1 Global Vitaros Market for Erectile Dysfunction Treatment, 2014 – 2019 (USD Million) 5.3 Uprima (Apomorphine) 5.4 Others (Topiglan, Melanocortin Activators, Gene Therapy) 5.4.1 Topiglan 5.4.2 Melanocortin Activators 5.4.3 Gene Therapy Chapter 6 Global Erectile Dysfunction Drugs Market, By Geography 6.1 Overview 7 Transparency Market Research

  8. Erectile Dysfunction Drugs Market 6.1.1 Global Erectile Dysfunction Drugs Market Revenue, By Geography, 2010 – 2019 (USD Million) 6.1.2 Comparative Analysis: Global Erectile Dysfunction Drugs Market, By Geography, 2012 & 2019 (Value %) 6.2 North America 6.2.1 North America Erectile Dysfunction Drugs Market, 2010 – 2014 (USD Million) 6.2.2 North America Erectile Dysfunction Drugs Market, 2015 - 2019 (USD Million) 6.3 Europe 6.3.1 Europe Erectile Dysfunction Drugs Market, 2010 – 2014 (USD Million) 6.3.2 Europe Erectile Dysfunction Drugs Market, 2015 - 2019 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Erectile Dysfunction Drugs Market, 2010 – 2014 (USD Million) 6.4.2 Asia-Pacific Erectile Dysfunction Drugs Market, 2015 - 2019 (USD Million) 6.5 Rest of the World (Row) 6.5.1 Rest of the World (Row) Erectile Dysfunction Drugs Market, 2010 – 2014 (USD Million) 6.5.2 Rest of the World (Row) Erectile Dysfunction Drugs Market, 2015 – 2019 (USD Million) Chapter 7 Competitive Landscape 7.1 Market Share Analysis: Global Erectile Dysfunction Drugs Market, 2012 (%) 7.1.1 Methodology 7.1.2 Analysis Chapter 8 Recommendations 8.1 Novel Drug Formulations and Genericization owing to Patent Expiration of well recognized ED Drugs 8.2 Mergers and Acquisitions to Strengthen Market Presence 8.3 Cost Containment Measures Chapter 9 Company Profiles 9.1 Apricus Biosciences, Inc. 9.1.1 Company Overview 8 Transparency Market Research

  9. Erectile Dysfunction Drugs Market 9.1.2 Business Strategies 9.1.3 Financial Overview 9.1.4 Product Portfolio 9.1.5 Recent Developments 9.2 Bayer AG 9.2.1 Company Overview 9.2.2 Business Strategies 9.2.3 Financial Overview 9.2.4 Product Portfolio 9.2.5 Recent Developments 9.3 Cristalia Produtos Quimicos Farmaceuticos Ltda. 9.3.1 Company Overview 9.3.2 Business Strategies 9.3.3 Product Portfolio 9.3.4 Recent Developments 9.4 Dong-A Pharmaceutical Co. Ltd. 9.4.1 Company Overview 9.4.2 Business Strategies 9.4.3 Financial Overview 9.4.4 Product Portfolio 9.4.5 Recent Developments 9.5 Eli Lilly And Company 9.5.1 Company Overview 9.5.2 Business Strategies 9.5.3 Financial Overview 9.5.4 Product Portfolio 9.5.5 Recent Developments 9.6 Meda Pharmaceuticals, Inc. 9 Transparency Market Research

  10. Erectile Dysfunction Drugs Market 9.6.1 Company Overview 9.6.2 Business Strategies 9.6.3 Product Portfolio 9.6.4 Recent Developments 9.7 Pfizer, Inc. 9.7.1 Company Overview 9.7.2 Business Strategies 9.7.3 Financial Overview 9.7.4 Product Portfolio 9.7.5 Recent Developments 9.8 S.K. Chemicals Co. Ltd. 9.8.1 Company Overview 9.8.2 Business Strategies 9.8.3 Financial Overview 9.8.4 Product Portfolio 9.8.5 Recent Developments 9.9 Vivus, Inc. 9.9.1 Company Overview 9.9.2 Business Strategies 9.9.3 Financial Overview 9.9.4 Product Portfolio 9.9.5 Recent Developments Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. 10 Transparency Market Research

  11. Erectile Dysfunction Drugs Market We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse The Market Research Blog : https://keshabblog.wordpress.com 11 Transparency Market Research

More Related